Detalhe da pesquisa
1.
Oncolytic strategy using new bifunctional HDACs/BRD4 inhibitors against virus-associated lymphomas.
PLoS Pathog
; 19(1): e1011089, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638143
2.
Identification of natural compounds tubercidin and lycorine HCl against small-cell lung cancer and BCAT1 as a therapeutic target.
J Cell Mol Med
; 26(9): 2557-2565, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35318805
3.
The Anti-COVID-19 Drug Remdesivir Promotes Oncogenic Herpesvirus Reactivation through Regulation of Intracellular Signaling Pathways.
Antimicrob Agents Chemother
; 66(3): e0239521, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35041508
4.
Enhanced DNA repair and genomic stability identify a novel HIV-related diffuse large B-cell lymphoma signature.
Int J Cancer
; 145(11): 3078-3088, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31044434
5.
Persistent bone marrow minimal residual disease as a "high-risk" disease feature in multiple myeloma.
Am J Hematol
; 96(9): E341-E344, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050985
6.
The transcriptional complex between the BCL2 i-motif and hnRNP LL is a molecular switch for control of gene expression that can be modulated by small molecules.
J Am Chem Soc
; 136(11): 4172-85, 2014 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24559432
7.
The dynamic character of the BCL2 promoter i-motif provides a mechanism for modulation of gene expression by compounds that bind selectively to the alternative DNA hairpin structure.
J Am Chem Soc
; 136(11): 4161-71, 2014 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24559410
8.
Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma.
Mol Cancer Ther
; 23(3): 316-329, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816504
9.
Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group.
Genes (Basel)
; 13(7)2022 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35885931
10.
Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma.
Blood Adv
; 6(3): 808-817, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807986
11.
Correction to "The Dynamic Character of the BCL2 Promoter i-Motif Provides a Mechanism for Modulation of Gene Expression by Compounds That Bind Selectively to the Alternative DNA Hairpin Structure".
J Am Chem Soc
; 138(35): 11408, 2016 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27571358
12.
The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure.
Pharmaceuticals (Basel)
; 14(2)2021 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33513764
13.
Bone remineralization of lytic lesions in multiple myeloma - The Arkansas experience.
Bone
; 146: 115876, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33556629
14.
The role of G-quadruplex/i-motif secondary structures as cis-acting regulatory elements.
Pure Appl Chem
; 82(8): 1609-1621, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21796223
15.
Frequent expression of activation-induced cytidine deaminase in diffuse large B-cell lymphoma tissues from persons living with HIV.
AIDS
; 34(14): 2025-2035, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32773475
16.
Activation-induced cytidine deaminase localizes to G-quadruplex motifs at mutation hotspots in lymphoma.
NAR Cancer
; 2(4): zcaa029, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33094287
17.
ProteoViz: a tool for the analysis and interactive visualization of phosphoproteomics data.
Mol Omics
; 16(4): 316-326, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32347222
18.
The i-motif in the bcl-2 P1 promoter forms an unexpectedly stable structure with a unique 8:5:7 loop folding pattern.
J Am Chem Soc
; 131(48): 17667-76, 2009 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-19908860
19.
Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas.
Viruses
; 11(12)2019 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31888174
20.
Simultaneous Drug Targeting of the Promoter MYC G-Quadruplex and BCL2 i-Motif in Diffuse Large B-Cell Lymphoma Delays Tumor Growth.
J Med Chem
; 60(15): 6587-6597, 2017 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28605593